Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 74,459,752
  • Shares Outstanding, K 287,190
  • Annual Sales, $ 17,117 M
  • Annual Income, $ 874,000 K
  • 60-Month Beta 0.76
  • Price/Sales 4.40
  • Price/Cash Flow 14.53
  • Price/Book 3.07
Trade BDX with:

Options Overview

Details
  • Implied Volatility 20.57%
  • Historical Volatility 11.62%
  • IV Percentile 25%
  • IV Rank 18.21%
  • IV High 40.95% on 10/30/20
  • IV Low 16.03% on 09/02/21
  • Put/Call Vol Ratio 0.82
  • Today's Volume 236
  • Volume Avg (30-Day) 878
  • Put/Call OI Ratio 2.15
  • Today's Open Interest 4,018
  • Open Int (30-Day) 9,281

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 2.42
  • Number of Estimates 10
  • High Estimate 2.46
  • Low Estimate 2.38
  • Prior Year 2.79
  • Growth Rate Est. (year over year) -13.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
244.57 +6.04%
on 08/25/21
264.00 -1.77%
on 09/08/21
+10.04 (+4.03%)
since 08/20/21
3-Month
237.54 +9.18%
on 08/09/21
264.00 -1.77%
on 09/08/21
+18.51 (+7.69%)
since 06/21/21
52-Week
219.50 +18.15%
on 09/25/20
267.37 -3.00%
on 01/12/21
+30.90 (+13.53%)
since 09/21/20

Most Recent Stories

More News
BD Partners with Washington State in Back-to-School Testing Effort

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been selected by the state of as a digitally read, rapid antigen test...

BDX : 259.79 (+0.20%)
Cybersecurity Gains Prominence in MedTech: 3 Stocks to Focus on

Technology-based healthcare stocks like Henry Schein (HSIC), Veeva Systems (VEEV) and BD (BDX) are expected to continue their rally over the next few months.

BDX : 259.79 (+0.20%)
HSIC : 75.85 (-0.16%)
MASI : 275.54 (+0.89%)
VEEV : 298.95 (+0.54%)
North America & Europe Oxygen Therapy Market- Outlook with Trends, Types, Applications, and Opportunity Outlook 2028

Research Nester has released a report titled which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness,...

BDX : 259.79 (+0.20%)
TFX : 378.83 (-0.07%)
GE : 96.54 (-3.28%)
AHPI : 7.55 (+7.09%)
FPH : 7.76 (-0.51%)
Percutaneous Coronary Intervention Market- Emerging Technologies, Trends, Industry Growth, Segments, Landscape and Demand by Forecast to 2027

Research Nester has released a reporttitled which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness,...

ABT : 125.60 (+0.58%)
BSX : 43.53 (-0.25%)
MDT : 128.07 (-0.51%)
TFX : 378.83 (-0.07%)
BDX : 259.79 (+0.20%)
Vicarious Surgical Inc. and D8 Holdings Corp. Announce Additional PIPE Commitments

Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes,...

DEH : 11.57 (+4.23%)
BDX : 259.79 (+0.20%)
NFH : 11.22 (-0.27%)
BD's (BDX) Latest Diagnostic System to Improve Lab Efficiency

BD's (BDX) new system is expected to address labs' needs for high-volume processing and increases in efficiency.

BDX : 259.79 (+0.20%)
ISRG : 1,014.73 (+0.07%)
HSIC : 75.85 (-0.16%)
IDXX : 663.66 (+0.59%)
BD to Present at Two Upcoming Virtual Healthcare Investor Conferences in September

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will present at the following upcoming virtual investor...

BDX : 259.79 (+0.20%)
BD (BDX) Veritor At-Home COVID-19 Test Receives EUA From FDA

EUA for BD's (BDX) At-Home COVID-19 test is expected to boost home testing to prevent outbreaks and limit the rise in COVID-19 cases from the Delta variant.

BDX : 259.79 (+0.20%)
ISRG : 1,014.73 (+0.07%)
HSIC : 75.85 (-0.16%)
IDXX : 663.66 (+0.59%)
Here's Why You Should Retain BD (BDX) Stock in Your Portfolio

Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and regulatory approvals.

BDX : 259.79 (+0.20%)
ISRG : 1,014.73 (+0.07%)
HSIC : 75.85 (-0.16%)
IDXX : 663.66 (+0.59%)
BD Receives Emergency Use Authorization for First At-Home COVID-19 Test to Use Smartphone to Interpret, Deliver Results

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization...

BDX : 259.79 (+0.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories....

See More

Key Turning Points

3rd Resistance Point 265.79
2nd Resistance Point 263.85
1st Resistance Point 261.56
Last Price 259.79
1st Support Level 257.33
2nd Support Level 255.39
3rd Support Level 253.10

See More

52-Week High 267.37
Last Price 259.79
Fibonacci 61.8% 249.08
Fibonacci 50% 243.43
Fibonacci 38.2% 237.79
52-Week Low 219.50

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar